Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) will present data ...

VISUfarma was created by GHO Capital in 2016 by combining the founder-owned Italian VISUfarma with the European commercial ...

Drug firm Lupin will establish a new manufacturing plant in Coral Springs, Florida. The investment totals USD 250 million ...

Mumbai: Lupin has announced that the company has received one observation from the U.S. Food and Drug Administration (USFDA) ...

Rivaroxaban for oral suspension, 1 mg/ml (RLD Xarelto) had a market value of roughly $11 million, per IQVIA July 2025 data.

Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced ...

Nicolas Atlan also discussed Spanish- and Portuguese-language content during a keynote appearance at the fifth annual ...

At 8:15 am, the Gift Nifty futures index had declined 98.50 points or 0.39%, indicating a gap-down start for the Sensex and ...

Lupin launches a strategic partnership program to expand its PrecisionSphere long-acting injectable platform. With FDA ...

Lupin’s subsidiary, Nanomi, has signed a definitive agreement to acquire VISUfarma, a portfolio company of GHO Capital ...

Lupin will present data from its Phase 1 a clinical trial evaluating LNP3693, a STING agonist, at the ESMO Congress in Berlin ...